Transfusion medicine and spongiform encephalopathy

Transfusion

Volumn 41, Issue 4, 2001, Pages 433-436

  Brown, P ^a  

^a MSC 4122 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ASSAY; BLOOD COMPONENT THERAPY; BLOOD TRANSFUSION; BRAIN SPONGIOSIS; CAPILLARY ELECTROPHORESIS; DIAGNOSTIC ACCURACY; DISEASE TRANSMISSION; EDITORIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH RISK POPULATION; HOST; HUMAN; NONHUMAN; PLASMA TRANSFUSION; POLYACRYLAMIDE GEL ELECTROPHORESIS; SCRAPIE AGENT; SCREENING; WESTERN BLOTTING;

BLOOD TRANSFUSION; HUMANS; PRION DISEASES;

EID: 0035042155     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2001.41040433.x     Document Type: Editorial

References (27)

1. Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease: Background, evolution, and current concerns
2. Distribution of the scrapie agent in the tissues of experimentally inoculated goats
3. Blood infectivity anal the prospects for a diagnostic screening test in Creutzfeldt-Jakob disease
4. Creutzfeldt-Jakob disease and blood transfusion
5. Risk factors for Creutzfeldt-Jakob disease: A reanalysis of case-control studies
6. Creutzfeldt-Jakob disease in the United States, 1979-1994: Using national mortality data to assess the possible occurrence of variant cases
7. European surveillance on Creutzfeldt-Jakob disease: A case-control study for medical risk factors
8. Creutzfeldt-Jakob disease anal blood transfusion
9. Surveillance for Creutzfeldt-Jakob disease among persons with hemophilia
10. Transmission of BSE by blood transfusion in sheep
11. Adaptation of the BSE agent to primates and comparison with Creutzfeldt-Jakob disease: Implications for human health
12. Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans
13. Titer, distribution, and transmissibility of blood-borne TSE infectivity
14. Infectivity in the blood of mice with a BSE-derived agent
15. Prion protein released by platelets
16. Application of a time-resolved fluoroimmunoassay for the analysis of normal prion protein in human blood and its components
17. Distribution of cell-associated prion protein in normal adult blood determined by flow cytometry
18. Different levels of prion protein (PrPc) expression on hamster, mouse and human blood cells
19. Transmission of BSE by blood transfusion
20. Assessment of the potential of plasma fractionation processes to remove causative agents of transmissible spongiform encephalopathy
21. Studies on the removal of abnormal prion protein by processes used in the manufacture of human plasma products
22. A direct relationship between the partitioning of the pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the purification of plasma proteins
23. Pathogenesis of experimental scrapie
24. The pathogenesis of transmissible spongiform encephalopathy: Routes to the brain and the erection of therapeutic barricades
25. Immunochemical determination of cellular prion protein in plasma from healthy subjects and patients with sporadic CJD or other neurologic diseases
26. Binding of disease-associated prion protein to plasminogen
27. A novel erythroid-specific marker of transmissible spongiform encephalopathies